The experience with intravesical BCG-immunotherapy in the management of superficial bladder cancer in the United Kingdom.
Robinson
M R
MR
Department of Urology, Pontefract General Infirmary, Frairwood, Pontefract, England.
D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use*; D006801:Humans; D006113:United Kingdom; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine